ArticleFrontiers in oncology2024

Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non-small cell lung cancer: a retrospective controlled real-world study.

Weipeng Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.